Ani Pharmaceuticals (ANIP) Other Working Capital Changes (2010 - 2026)

Ani Pharmaceuticals has disclosed Other Working Capital Changes across 17 years of filings, most recently posting -$2.7 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$2.7 million, down 168.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 150.74% YoY), and the FY2025 annual result was $5.0 million, up 335.98% from the prior year.
• Other Working Capital Changes came in at -$2.7 million for Q1 2026 at Ani Pharmaceuticals, down from $4.5 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $8.4 million in Q4 2023 to a low of -$9.8 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $64000.0 (2023), against an average of $589470.6.
• Peak annual rise in Other Working Capital Changes reached 415.6% in 2025, while the deepest fall reached 2219.58% in 2025.
• Ani Pharmaceuticals' Other Working Capital Changes stood at $3.4 million in 2022, then surged by 145.36% to $8.4 million in 2023, then sank by 79.79% to $1.7 million in 2024, then soared by 163.44% to $4.5 million in 2025, then slumped by 160.25% to -$2.7 million in 2026.
• The last three Other Working Capital Changes figures came in at -$2.7 million (Q1 2026), $4.5 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.